AFYREN Announces Its Financial Calendar for Fiscal Year 2025

AFYREN, a French greentech company specializing in biobased, low-carbon ingredients, has announced its financial calendar for the fiscal year 2025. The company, which offers manufacturers biobased ingredients through a unique fermentation technology based on a circular model, aims to start continuous production of its AFYREN NEOXY plant in 2025. AFYREN's cash position stood at around €33 million as of December 31, 2024, providing the company with sufficient capital to support the continuous production phase and future development.

AFYREN's financial calendar for 2025 includes the following key events:

1. 2024 Full-Year Results: Thursday, March 27, 2025
2. Annual General Meeting: Tuesday, June 17, 2025
3. 2025 Half-Year Results: Thursday, September 25, 2025

These events will provide investors and stakeholders with crucial updates on the company's financial performance and progress towards its strategic objectives.

AFYREN's Chief Executive Officer, Nicolas SORDET, stated that the company is addressing typical issues associated with the startup phase of innovative technology. With the production launch and first sales in 2024, AFYREN realized that extra time was needed to reach continuous production levels, which are now expected during 2025. The company secured a new non-dilutive financing from its investment banks and new partners, totaling €10 million, to support the start-up and subsequent ramp-up of the AFYREN NEOXY plant. This financing is indexed to CSR criteria, reflecting AFYREN's commitment to sustainability and stakeholder engagement.

AFYREN NEOXY's continuous production is expected to start in 2025, compared with its initial forecast of 2024. The break-even point is expected after a few quarters of activity. Investors should monitor the company's progress towards these milestones and its financial performance throughout the year.